Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 May 22:10:952.
doi: 10.3389/fmicb.2019.00952. eCollection 2019.

Nucleoside Analogues as Antibacterial Agents

Affiliations
Review

Nucleoside Analogues as Antibacterial Agents

Jessica M Thomson et al. Front Microbiol. .

Abstract

The rapid increase in antibiotic-resistant bacteria has emphasized the urgent need to identify new treatments for bacterial infections. One attractive approach, reducing the need for expensive and time-consuming clinical trials, is to repurpose existing clinically approved compounds for use as antibacterial agents. Nucleoside analogues are commonly used for treating viral and fungal infections, as well as for treating cancers, but have received relatively little attention as treatments for bacterial infections. However, a significant number of clinically approved derivatives of both pyrimidines and purines including halogenated, thiolated, and azolated compounds have been shown to have antibacterial activity. In the small number of studies carried out to date, such compounds have shown promise in treating bacterial infections. Here, we review the mechanisms of action and antibacterial activities of nucleoside analogues that can potentially be repurposed for treating infections as well as considering possible limitations in their usage.

Keywords: antibacterial agents; antibiotic resistance; antimicrobial; multidrug-resistant bacteria; purine analogues; pyrimidine analogues; repurposed antibiotics.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pathways by which pyrimidine and purine analogues are metabolized and become incorporated into DNA and RNA. Inhibition of enzymes by nucleoside analogues and their metabolites is also shown (⊣). (A) Pyrimidine analogues. (B) Purine analogues. Abbreviations: HPRT, hypoxanthine-guanine phosphoribosyl transferase; IMP, inosine monophosphate; RNR, ribonucleotide reductase; TK, thymidylate kinase; TMK, deoxythymidine monophosphate kinase; TS, thymidylate synthase; UDP-GlcNAc, uridine diphosphate N-acetylglucosamine; XMP, xanthosine monophosphate.
Figure 2
Figure 2
Structures of pyrimidines, purines, and their analogues, with substituted atoms highlighted. (A) Deoxycytidine and its analogue. (B) Thymidine and its analogues. (C) Cytosine, uracil, and fluorinated pyrimidines. (D) Hypoxanthine, guanine, and their analogues.

References

    1. Akoachere M., Squires R. C., Nour A. M., Angelov L., Brojatsch J., Abel-Santos E. (2007). Identification of an in vivo inhibitor of Bacillus anthracis spore germination. J. Biol. Chem. 282, 12112–12118. 10.1074/jbc.M611432200, PMID: - DOI - PubMed
    1. Alvarez Z., Lee K., Abel-Santos E. (2010). Testing nucleoside analogues as inhibitors of Bacillus anthracis spore germination in vitro and in macrophage cell culture. Antimicrob. Agents Chemother. 54, 5329–5336. 10.1128/AAC.01029-10, PMID: - DOI - PMC - PubMed
    1. Alvarez P., Marchal J. A., Boulaiz H., Carrillo E., Velez C., Rodriguez-Serrano F., et al. . (2012). 5-Fluorouracil derivatives: a patent review. Expert Opin. Ther Pat. 22, 107–123. 10.1517/13543776.2012.661413, PMID: - DOI - PubMed
    1. Bennett J. E. (1977). Flucytosine. Ann. Intern. Med. 86, 319–322. 10.7326/0003-4819-86-3-319, PMID: - DOI - PubMed
    1. Boston Interhospital Virus Study Group and NIAID-Sponsored Cooperative Antiviral Clinical Study (1975). Failure of high dose 5-iodo-2′-deoxyuridine in the therapy of herpes simplex virus encephalitis. Evidence of unacceptable toxicity. N. Engl. J. Med. 292, 599–603. 10.1056/NEJM197503202921201, PMID: - DOI - PubMed

LinkOut - more resources